preview stronger dollar drag
us dollar headwind off-set healthcarefirst
report result octob australia/u time revis
revenu slightli lower reflect lower rest world row revenu
follow strengthen usd lower america mask growth cycl
growth off-set inclus healthcarefirst revenu
pa brightre follow acquisit late america expect
devic growth mask growth build prior quarter quietair
vent/mask popular revenu ep non-gaap forecast in-lin
expect stabl price next round reimburs chang due
jan competit bid process current propos chang indic price
chang low singl digit durable/hom medic equip
dme/hm closures/consolid experienc last year slowed/ceas allevi
price pressur expect devic volum growth remain current pace mask
continu grow quietair vent roll addit mask type eg airfit
forecast revenu organ growth brightre whilst brightre
expand via new modul data analyt new client home health hospic
believ upsid reinvest brightre busi see
signific chang product mix materi move gross margin
remain bullish maintain buy rate slight decreas po
lower previous tsr includ dividend yield
aud po rise result currenc gain
net dbt
full definit iqmethod sm measur see page
employ non-u affili mlpf registered/qualifi research analyst
finra rule
refer import disclosur inform certain bofa merril lynch entiti take
respons report particular jurisdict
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
outsid equiti interest npat
chang work capit
 flow item int tax
 flow oper
oper
acquisit dispos invest
 flow invest
invest
 flow financ
financ
return capit employ
return equiti
iqmethod sm qualiti earn
full definit iqmethod sm measur see page
lead develop
manufactur medic devic mask cloud-
base softwar applic diagnos treat
manag respiratori disord headquart
san diego california focuss
connect health deliv better outcom
sleep apnea chronic obstruct pulmonari
outpac industri growth
market share place
everi market oper benefit
clinic data-captur proprietari
softwar boost therapi complianc
rate increas mask accessori growth
addit market develop
market activ target
moder sever osa suffer world-wide
price book valu
 revenue
sg revenue
tabl chang fx assumpt
price object per share base dcf
valuat dcf use wacc termin growth rate beta
po would trade premium key competitor phia pe basi
think justifi given superior growth potenti
downsid risk po market educ effort achiev
expect revenu growth center medicar medicaid servic
propos chang us reimburs reimburs chang health
ministri phi technolog advanc competitor product fx
lyann harrison herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
